Viewing Study NCT03869320


Ignite Creation Date: 2025-12-25 @ 4:27 AM
Ignite Modification Date: 2025-12-26 @ 3:30 AM
Study NCT ID: NCT03869320
Status: COMPLETED
Last Update Posted: 2020-01-10
First Post: 2019-03-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of ACT-1004-1239 in Healthy Male Subjects
Sponsor: Idorsia Pharmaceuticals Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-03-25
Start Date Type: ACTUAL
Primary Completion Date: 2019-07-11
Primary Completion Date Type: ACTUAL
Completion Date: 2019-07-11
Completion Date Type: ACTUAL
First Submit Date: 2019-03-08
First Submit QC Date: None
Study First Post Date: 2019-03-11
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-01-08
Last Update Post Date: 2020-01-10
Last Update Post Date Type: ACTUAL